Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
National Retail Properties (NNN) Prices 7M Share Common Offering at $56.50/Sh
-
Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
-
National Retail Properties, Inc. Prices Offering Of Common Stock
-
American Finance Trust Announces Offering of 7.50% Series A Cumulative Redeemable Perpetual Preferred Stock
-
Leap Therapeutics to Present at Upcoming Investor Conferences
-
SCYNEXIS, Inc. to Participate in Two Upcoming Investor Conferences
-
Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences
-
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
-
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
-
Zynerba Pharmaceuticals to Present at Two Upcoming Conferences
-
Albireo to Participate in Upcoming Investor Conferences
-
Eyenovia to Present at Two Upcoming Investor Conferences
-
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in September
-
Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences
-
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in September
-
Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences
-
Exicure to Present at Upcoming Investor Conferences
-
Intec Pharma to Participate in September Investment Conferences
-
NovaBay Pharmaceuticals to Present at Two Investment Conferences in September
-
Immunic, Inc. to Participate in Scientific and Investor Conferences in September
-
Eiger BioPharmaceuticals to Participate in September Conferences
-
Millendo Therapeutics to Participate in September Investor Conferences
-
Novus Therapeutics to Participate in Two Upcoming Investor Conferences
-
Allena Pharmaceuticals to Participate in Upcoming Investor Conferences in September
-
Allena Pharmaceuticals to Participate in Upcoming Investor Conferences in September
-
Zymeworks to Participate in Upcoming Investor Conferences
-
Bellicum Pharmaceuticals to Participate in Three Healthcare Investor Conferences during September
-
OFS Credit Company, Inc. Announces Results of Rights Offering
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
-
Ladenburg Thalmann (LTS) Declares $0.0125 Quarterly Dividend; 2.5% Yield
-
Ladenburg Declares Quarterly Dividend on Common Stock
-
RedHill Biopharma to Present at Upcoming Investor Conferences in September
-
RedHill Biopharma to Present at Upcoming Investor Conferences in September
-
OFS Credit Company, Inc. Announces Extension of Expiration of Rights Offering
-
Arcturus Therapeutics To Present at Two Investor Conferences in September
-
Ladenburg Thalmann Downgrades Oasis Petroleum (OAS) to Neutral
-
Ladenburg Thalmann Downgrades Range Resources (RRC) to Neutral
-
Ladenburg Thalmann Downgrades HighPoint Resources Corp (HPR) to Neutral
-
Ladenburg Thalmann Downgrades Abraxas Petroleum (AXAS) to Neutral
-
FTJ FundChoice Showcases Modernized TAMP Experience during 34-Stop U.S. Event Tour
-
Ladenburg Concludes Second Consolidated National Conference Of 2019 With Launch Of Innovative 401(k) Offering For Advisors' Business Clients
-
Bellicum Pharmaceuticals Announces Aggregate Gross Proceeds of $69.6 Million from $139.6 Million Public Offering and Private Placement
-
GreenAcreage Announces Completion of $141 million Private Placement
-
CORRECTING and REPLACING - Bellicum Pharmaceuticals, Inc.
-
Canopy Growth Corp (CGC) PT Lowered to $42 at Ladenburg Thalmann
-
Oncolytics Biotech(R) Announces Closing of Its Public Offering of Common Shares and Warrants
-
Bellicum Pharma (BLCM) Prices $139.6 Million Public Offering and Private Placement
-
Bellicum Pharmaceuticals Announces Pricing of Bellicum Pharmaceuticals Announces Pricing of $139.6 Million Public Offering and Private Placement
-
Dolphin Entertainment (DLPN) PT Raised to $2.40 at Ladenburg Thalmann
-
Form 13F-NT Ladenburg Thalmann Asset For: Jun 30

